INS and metabolic syndrome: Notably, individuals with coexistence of T2DM and metabolic syndrome exhibited a reduction of 59% in insulin-mediated myocardial glucose metabolism than subjects with T2DM without MetS and a reduction of 68% as compared with control subjects.